Suzetrigine, to be sold under the brand name Journavx, is the first new type of pain medicine approved by the FDA in more ...

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Recent developments, however, suggest that strategies to treat pain are starting to match its complexity with a new ...

Metastatic breast cancer and breast cancer treatment can cause symptoms that produce appetite loss, but there are strategies to help. Here are the top tips.

The benchmark indices may attempt to rebound amid rangebound trading and rising volatility. Below are some trading ideas for ...

Arthritis Community Services of Mosaic offers resources and a course for people struggling with chronic pain. The group meets from 2 to 4 p.m. every Thursday at the Joyce Raye Patterson 50+ Activity ...

Stanford Effective Altruism, Stanford Student Pre-Veterinary Committee and Stanford Animal Service Project talk about the ...

How do you balance the desire to be liked with the need to be respected? Organizational psychologist Bob Sutton has a handy rule for leaders.

He will also take up a visiting fellowship at the Hoover Institution, a think tank based at Stanford University in California. Sunak, who studied philosophy, politics and economics at Oxford ...

More than 30 percent of adults in the U.S. are living with chronic or severe pain. If you’re part of that statistic, you know how devastating living with severe or daily pain can be. Treating ...

and I'm not sure if there's a winner. Apparently, there are moms out there who have birthed several children that will state the pain experienced in one particular instance is much worse, just as ...